Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells.

Ovarian cancer is developed from a single layer of thin epithelial cells covering the surface of ovary, named human ovarian surface epithelial cells. Like all primary human cells, human ovarian surface epithelial cells have a finite life span and will go into senescence and eventually die when cultured in vitro. Immortalized human ovarian surface epithelial cells will provide an important model system with which to study ovarian cancer initiation and progression. Here, we show that silencing p53 expression with retrovirus-mediated small interfering RNA can delay the senescence and extend cell passage number, but is not sufficient to immortalize normal ovarian surface epithelial cells. Introduction of the catalytic subunit of telomerase is similarly insufficient to achieve immortalization. However, concurrent disruption of p53 expression with small interfering RNA retroviral constructs and ectopic expression of the catalytic subunit of telomerase was sufficient to induce cellular immortalization in 3 of 3 human ovarian surface epithelial cell cultures tested. The immortalization is associated with increased telomerase activity and telomere length, and attenuated response of cell-cycle regulatory proteins to irradiation. The resultant immortal cells continued to express the same specific cytokeratins 8 and 18 as parental cells did, indicating that the epithelial characters are still maintained in the immortal cells. In addition, the immortalized cells are non-tumorigenic and nearly diploid, which is in constrast with one immortalized by SV40 T/t antigens and hTERT. As both p53 pathway dysfunction and activation of telomerase are commonly present in human ovarian cancer, these immortal cells provide an authetic cell model system for the study of the human ovarian cancer initiation, progression, differentiation and chemoprevention.

[1]  N. Auersperg,et al.  Human ovarian surface epithelium in primary culture , 1984, In Vitro.

[2]  M. Suzuki,et al.  Immortalization of human small airway epithelial cells by ectopic expression of telomerase. , 2005, Carcinogenesis.

[3]  A. Jemal,et al.  Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.

[4]  T. Jacks,et al.  Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer , 2005, Nature Medicine.

[5]  J. Pollack,et al.  Immortalization of Human Bronchial Epithelial Cells in the Absence of Viral Oncoproteins , 2004, Cancer Research.

[6]  S. Clark,et al.  Alterations in the p16INK4a and p53 tumor suppressor genes of hTERT-immortalized human fibroblasts , 2004, Oncogene.

[7]  W. Hahn,et al.  A Genetically Defined Model for Human Ovarian Cancer , 2004, Cancer Research.

[8]  R. Bast,et al.  Inhibition of Breast and Ovarian Tumor Growth through Multiple Signaling Pathways by Using Retrovirus-mediated Small Interfering RNA against Her-2/neu Gene Expression* , 2004, Journal of Biological Chemistry.

[9]  W. Hahn,et al.  In situ human telomerase reverse transcriptase expression pattern in normal and neoplastic ovarian tissues. , 2004, Oncology reports.

[10]  Gong Yang,et al.  Silencing of H-ras gene expression by retrovirus-mediated siRNA decreases transformation efficiency and tumorgrowth in a model of human ovarian cancer , 2003, Oncogene.

[11]  A. Flesken-Nikitin,et al.  Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium. , 2003, Cancer research.

[12]  Barbara C Vanderhyden,et al.  Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. , 2003, Cancer research.

[13]  Judith Campisi,et al.  The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. , 2002, Cancer research.

[14]  W. Hahn,et al.  A Two-Stage, p16INK4A- and p53-Dependent Keratinocyte Senescence Mechanism That Limits Replicative Potential Independent of Telomere Status , 2002, Molecular and Cellular Biology.

[15]  L. Gollahon,et al.  Telomerase Protects Cancer-Prone Human Cells from Chromosomal Instability and Spontaneous Immortalization , 2002, Cancer biology & therapy.

[16]  W. Forrester,et al.  A DNA vector-based RNAi technology to suppress gene expression in mammalian cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[17]  H. Varmus,et al.  Induction of ovarian cancer by defined multiple genetic changes in a mouse model system. , 2002, Cancer cell.

[18]  E. Schmelz,et al.  Spontaneous malignant transformation of human ovarian surface epithelial cells in vitro. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  M. Nitta,et al.  Characterization and tumorigenicity of human ovarian surface epithelial cells immortalized by SV40 large T antigen. , 2001, Gynecologic oncology.

[20]  A. Lenferink,et al.  Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Kigawa,et al.  Alteration of Telomerase Activity Associated With Development and Extension of Epithelial Ovarian Cancer , 1998, Obstetrics and gynecology.

[22]  R. Berkowitz,et al.  Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs). , 1995, Experimental cell research.

[23]  R. Bast,et al.  Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer. , 1993, Journal of the National Cancer Institute.

[24]  P. Humphrey,et al.  Mutation and overexpression of p53 in early-stage epithelial ovarian cancer. , 1993, Obstetrics and gynecology.

[25]  P. Kruk,et al.  Simian virus 40-transformed human ovarian surface epithelial cells escape normal growth controls but retain morphogenetic responses to extracellular matrix. , 1992, American journal of obstetrics and gynecology.

[26]  S. Hirohashi,et al.  High Incidence of p53 Gene Mutation in Human Ovarian Cancer and Its Association with Nuclear Accumulation of p53 Protein and Tumor DNA Aneuploidy , 1992, Japanese journal of cancer research : Gann.

[27]  S. Sukumar,et al.  Mutations in p53 as potential molecular markers for human breast cancer. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P. Kruk,et al.  A simplified method to culture human ovarian surface epithelium. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[29]  John Paul,et al.  Tissue culture. Methods and applications. , 1974 .

[30]  L. Hayflick Subculturing Human Diploid Fibroblast Cultures11Supported, in part, by research Grant HD 04004 from the National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland. , 1973 .

[31]  L. Hayflick THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.

[32]  L. Hayflick,et al.  THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS 1 , 1964 .